The Lincolnian Online logo

The Latest Headlines at The Lincolnian Online

Image about Cabaletta Bio (NASDAQ:CABA) Trading Up 7.8%  – Still a Buy?

Cabaletta Bio (NASDAQ:CABA) Trading Up 7.8% – Still a Buy?

Cabaletta Bio, Inc. (NASDAQ:CABA – Get Free Report)’s stock price shot up 7.8% during trading on Thursday . The company traded as high as $3.28 and last traded at $3.2220. Approximately 3,384,207 shares were traded during... More of this article »
Image about Babcock International Group (OTCMKTS:BCKIY) Trading Up 7%  – What’s Next?

Babcock International Group (OTCMKTS:BCKIY) Trading Up 7% – What’s Next?

Babcock International Group PLC (OTCMKTS:BCKIY – Get Free Report) traded up 7% during trading on Thursday . The stock traded as high as $14.1260 and last traded at $14.1260. 955 shares were traded during mid-day trading, a decline... More of this article »
Image about AbbVie (NYSE:ABBV) Sets New 12-Month High  – Should You Buy?

AbbVie (NYSE:ABBV) Sets New 12-Month High – Should You Buy?

AbbVie Inc. (NYSE:ABBV – Get Free Report)’s share price reached a new 52-week high during trading on Thursday . The company traded as high as $258.45 and last traded at $259.20, with a volume of 817884 shares. The stock... More of this article »
Image about iShares Interest Rate Hedged Corporate Bond ETF (NYSEARCA:LQDH) Sees Strong Trading Volume  – Time to Buy?

iShares Interest Rate Hedged Corporate Bond ETF (NYSEARCA:LQDH) Sees Strong Trading Volume – Time to Buy?

iShares Interest Rate Hedged Corporate Bond ETF (NYSEARCA:LQDH – Get Free Report) saw strong trading volume on Thursday . 231,165 shares changed hands during mid-day trading, an increase of 356% from the previous session’s... More of this article »
Image about NEC (OTCMKTS:NIPNF) Shares Gap Up   – Still a Buy?

NEC (OTCMKTS:NIPNF) Shares Gap Up – Still a Buy?

NEC Co. (OTCMKTS:NIPNF – Get Free Report)’s share price gapped up before the market opened on Thursday . The stock had previously closed at $24.39, but opened at $25.95. NEC shares last traded at $25.95, with a volume of... More of this article »
Image about Teradyne (NASDAQ:TER) Trading Down 6.3%  – Here’s What Happened

Teradyne (NASDAQ:TER) Trading Down 6.3% – Here’s What Happened

Teradyne, Inc. (NASDAQ:TER – Get Free Report)’s stock price was down 6.3% during mid-day trading on Thursday . The stock traded as low as $411.00 and last traded at $400.3830. Approximately 606,818 shares traded hands during... More of this article »
Image about Sharplink Gaming (NASDAQ:SBET) Shares Up 7.4%  – What’s Next?

Sharplink Gaming (NASDAQ:SBET) Shares Up 7.4% – What’s Next?

Shares of Sharplink Gaming Inc. (NASDAQ:SBET – Get Free Report) traded up 7.4% during trading on Thursday . The stock traded as high as $5.63 and last traded at $5.5550. 4,872,628 shares were traded during mid-day trading, a... More of this article »
Image about Indra Sistemas (OTCMKTS:ISMAY) Stock Price Up 10.9%  – What’s Next?

Indra Sistemas (OTCMKTS:ISMAY) Stock Price Up 10.9% – What’s Next?

Indra Sistemas S.A. Unsponsored ADR (OTCMKTS:ISMAY – Get Free Report) shares shot up 10.9% on Thursday . The company traded as high as $29.8350 and last traded at $29.8350. Approximately 512 shares traded hands during mid-day... More of this article »
Image about Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) Sees Large Drop in Short Interest

Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) Sees Large Drop in Short Interest

Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY – Get Free Report) was the target of a large decline in short interest in June. As of June 15th, there was short interest totaling 142,536 shares, a decline of 36.8% from the May 31st... More of this article »
Image about CRISPR Therapeutics Target of Unusually High Options Trading (NASDAQ:CRSP)

CRISPR Therapeutics Target of Unusually High Options Trading (NASDAQ:CRSP)

CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) was the target of unusually large options trading on Thursday. Stock traders bought 7,023 call options on the stock. This is an increase of approximately 85% compared to... More of this article »
Image about Garden Stage Limited (NASDAQ:GSIW) Short Interest Down 36.5% in June

Garden Stage Limited (NASDAQ:GSIW) Short Interest Down 36.5% in June

Garden Stage Limited (NASDAQ:GSIW – Get Free Report) was the recipient of a large drop in short interest in June. As of June 15th, there was short interest totaling 7,263 shares, a drop of 36.5% from the May 31st total of 11,433... More of this article »
Image about Mitsui O.S.K. Lines (OTCMKTS:MSLOY) Sees Large Volume Increase  – Should You Buy?

Mitsui O.S.K. Lines (OTCMKTS:MSLOY) Sees Large Volume Increase – Should You Buy?

Shares of Mitsui O.S.K. Lines, Ltd. (OTCMKTS:MSLOY – Get Free Report) saw an uptick in trading volume on Thursday . Approximately 57,825 shares were traded during trading, an increase of 32% from the previous session’s... More of this article »
Image about iPath Series B S&P 500 VIX Short-Term Futures ETN Target of Unusually Large Options Trading (BATS:VXX)

iPath Series B S&P 500 VIX Short-Term Futures ETN Target of Unusually Large Options Trading (BATS:VXX)

iPath Series B S&P 500 VIX Short-Term Futures ETN (BATS:VXX – Get Free Report) was the target of unusually large options trading activity on Thursday. Stock investors bought 68,318 put options on the company. This represents... More of this article »
Image about iShares LifePath Target Date 2035 ETF (NYSEARCA:ITDC) Short Interest Update

iShares LifePath Target Date 2035 ETF (NYSEARCA:ITDC) Short Interest Update

iShares LifePath Target Date 2035 ETF (NYSEARCA:ITDC – Get Free Report) was the target of a significant decline in short interest during the month of June. As of June 15th, there was short interest totaling 4,231 shares, a decline... More of this article »
Image about Research Analysts’ Weekly Ratings Updates for Best Buy (BBY)

Research Analysts’ Weekly Ratings Updates for Best Buy (BBY)

Several analysts have recently updated their ratings and price targets for Best Buy (NYSE: BBY): 6/24/2026 – Best Buy had its price target lowered by Loop Capital from $85.00 to $82.00. They now have a “buy” rating... More of this article »